CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS
The present invention provides a compound of Formula I:wherein R1 is H, halogen, C1-C3 alkyl, or C1-C3 alkoxy;R2 is H or halogen; andX is O, OCH2, or CH2, or a pharmaceutically acceptable salt thereof, wherein the compound of Formula I, or pharmaceutically acceptable salt thereof is useful for treat...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
20.07.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides a compound of Formula I:wherein R1 is H, halogen, C1-C3 alkyl, or C1-C3 alkoxy;R2 is H or halogen; andX is O, OCH2, or CH2, or a pharmaceutically acceptable salt thereof, wherein the compound of Formula I, or pharmaceutically acceptable salt thereof is useful for treating autoimmune and inflammatory diseases, such as atopic dermatitis, rheumatoid arthritis, and lupus nephritis. |
---|---|
Bibliography: | Application Number: US202318175812 |